Averin Capital Acquisition Corp (NASDAQ: ACAAU) completed a $250,000,000 initial public offering of 25,000,000 units at $10.00 per unit, with trading beginning February 19, 2026. Each unit equals one Class A ordinary share plus one-sixth of a redeemable warrant, exercisable at $11.50 per share.
The company granted a 45-day over-allotment option for 3,750,000 units and placed $2,000,000 in trust. Averin is a blank check company targeting technology and health sector combinations; registration was declared effective by the SEC on February 18, 2026.
Loading...
Loading translation...
Positive
Gross proceeds of $250,000,000 from the IPO
Units began trading on Nasdaq under ticker ACAAU
45-day over-allotment option for 3,750,000 units (15%)
Negative
Company is a blank check vehicle with no operating business
Only $2,000,000 placed in trust from the offering
Outstanding warrants exercisable at $11.50 may cause dilution
Key Figures
IPO units:25,000,000 unitsIPO price:$10.00 per unitGross proceeds:$250,000,000+5 more
8 metrics
IPO units25,000,000 unitsInitial public offering size
IPO price$10.00 per unitInitial public offering price
Gross proceeds$250,000,000Gross proceeds from initial public offering
Trust amount$2,000,000Placed in trust from IPO and private placement proceeds
Warrant ratio1/6 redeemable warrant per unitEach unit composition
Warrant exercise price$11.50 per shareExercise price for each whole warrant
Over-allotment units3,750,000 unitsUnderwriter 45-day option to cover over-allotments
SEC effectiveness dateFebruary 18, 2026Registration statement declared effective by SEC
Market Reality Check
Price:$10.00Vol:Volume 52,863 is at 0.01x...
low vol
$10.00Last Close
VolumeVolume 52,863 is at 0.01x the 20-day average of 4,473,016, typical for an early IPO session.low
TechnicalPrice at 10 versus 200-day MA of 10 (relationship flagged as 'above' in technical data).
Market Pulse Summary
This announcement confirms the closing of the IPO at $10.00 per unit, generating gross proceeds of $...
Analysis
This announcement confirms the closing of the IPO at $10.00 per unit, generating gross proceeds of $250,000,000 and establishing a trust funded at $10.00 per unit sold. As a blank check company, future developments will center on identifying a business combination at the intersection of technology and health. Key items to watch include the use of proceeds, timing and terms of any merger, and how warrant exercise at $11.50 per share might affect shareholders.
Key Terms
initial public offering, redeemable warrant, over-allotments, private placement, +4 more
8 terms
initial public offeringfinancial
"announced today the closing of its initial public offering of 25,000,000 units."
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
redeemable warrantfinancial
"one Class A ordinary share of the Company and one-sixth of one redeemable warrant,"
A redeemable warrant is a financial tool that gives its holder the right to buy shares of a company at a fixed price within a certain period. If the holder chooses to do so, the company can buy back or cancel the warrant before it expires, often to encourage investment or manage share issuance. For investors, it provides an option to potentially buy shares at a favorable price while offering some flexibility for the issuing company.
over-allotmentsfinancial
"45-day option to purchase up to an additional 3,750,000 units ... to cover over-allotments, if any."
An over-allotment is a temporary extra batch of shares that the underwriters of a stock offering are allowed to sell beyond the original amount, with the right to buy those shares back later. Think of it as spare tickets sold to meet demand and then reclaimed if needed to keep the market orderly; it helps stabilize the stock price after an offering and can affect short-term supply and potential dilution, which matters to investors tracking price and ownership stakes.
private placementfinancial
"initial public offering and a simultaneous private placement of units, $2,000,000..."
A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.
blank check companyfinancial
"The Company is a blank check company formed for the purpose of effecting a merger,"
A blank check company is a publicly listed shell that raises money from investors before naming a specific business to buy or merge with, similar to handing a cashier a signed check and asking them to fill in the payee later. It matters to investors because it offers a faster, often cheaper path for private firms to become public, but carries extra risk since returns depend on the organizers’ ability to find a good deal and on limited information about the future business.
registration statementregulatory
"A registration statement relating to the securities was declared effective..."
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.
Securities and Exchange Commissionregulatory
"declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on February 18, 2026."
A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.
book-running managerfinancial
"Deutsche Bank Securities Inc. acted as sole book-running manager for the offering."
A book-running manager is the lead organizer responsible for coordinating a large financial sale, such as issuing new stocks or bonds. They oversee preparing all necessary documents, setting the sale’s price, and finding buyers, much like a concert promoter arranging a major event. Their role matters to investors because they help ensure the offering is successfully sold at the best possible terms.
AI-generated analysis. Not financial advice.
New York, NY, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Averin Capital Acquisition Corp. (the “Company”) announced today the closing of its initial public offering of 25,000,000 units. The offering was priced at $10.00 per unit, resulting in gross proceeds of $250,000,000.
The Company’s units began trading on February 19, 2026 on the Nasdaq Global Stock Market LLC (“Nasdaq”) under the ticker symbol “ACAAU.” Each unit consists of one Class A ordinary share of the Company and one-sixth of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “ACAA” and “ACAAW,” respectively. The Company has granted the underwriter a 45-day option to purchase up to an additional 3,750,000 units at the initial public offering price to cover over-allotments, if any.
Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of units, $2,000,000 (or $10.00 per unit sold in the offering) was placed in trust.
The Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company currently intends to concentrate its efforts in identifying businesses that are at the intersection of the technology and health industries.
The Company’s management team is led by David Berry, Chief Executive Officer and Chairman, and Alex Lau, its Chief Financial Officer. The Board also includes Ulrik Schulze, Graeme Bell, and Mary T. Szela.
Deutsche Bank Securities Inc. acted as sole book-running manager for the offering.
A registration statement relating to the securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on February 18, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
FORWARD-LOOKING STATEMENTS
This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering and the anticipated use of the net proceeds thereof. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
When did Averin Capital Acquisition Corp (ACAAU) begin trading on Nasdaq?
Averin Capital Acquisition Corp began trading on Nasdaq on February 19, 2026. According to the company, units started trading under the ticker ACAAU, with separate Class A shares and warrants expected to trade later as ACAA and ACAAW.
What does one Averin Capital unit include and what is the warrant exercise price for ACAAU?
Each unit includes one Class A ordinary share and one-sixth of a redeemable warrant. According to the company, each whole warrant permits purchase of one Class A share at an exercise price of $11.50 per share.
How much money did Averin Capital raise in its initial public offering (ACAAU)?
Averin Capital raised $250,000,000 from the IPO, selling 25,000,000 units at $10.00 each. According to the company, gross proceeds reflect the offering price before underwriting fees and expenses.
What over-allotment option did Averin grant in the ACAAU offering and for how long?
The company granted the underwriter a 45-day option to purchase up to 3,750,000 additional units. According to the company, this option covers potential over-allotments at the initial public offering price.
How much was placed in trust from Averin Capital's IPO and what does that mean for ACAAU investors?
The company placed $2,000,000 in trust from the offering proceeds. According to the company, trust funds are held to support the SPAC structure while it seeks a qualifying business combination in the technology and health sectors.
Who are the named executives and board members for Averin Capital (ACAAU)?
Management is led by David Berry as CEO and chairman, with Alex Lau as CFO. According to the company, the board includes Ulrik Schulze, Graeme Bell, and Mary T. Szela, overseeing SPAC strategy and deal evaluation.
